Early memory diagnostics to identify people at risk
Any diagnosis, however late, is better than no diagnosis. Yet in terms of securing appropriate medical and social care, only early diagnosis during the pre-clinical and asymptomatic phase holds the potential for modification of disease progression. Recent technological developments and the use of digital tools in healthcare allow the support of earlier and more reliable diagnosis including objective patient monitoring over time. Furthermore, particularly in the technology-rich environment of Switzerland, such tools may become capable of estimating drug efficacy in a personalized manner, and digital therapeutics may be used as targeted, interventions to slow cognitive decline and maintain the patient’s independence for longer. We believe that the use of early diagnosis should become more widespread, so that appropriate support may be made available to those diagnosed. Dementia screening at an annual check-up should be considered for those over 60 years of age, and insurance companies may need to provide patient journey packages in which dementia patients are cared for in an integrated solution over time.